Tolvaptan CAS 150683-30-0 API Tsabta > 99.0% (HPLC)

Takaitaccen Bayani:

Sunan Sinadari: Tolvaptan

Saukewa: 150683-30-0

Tsaftace (HPLC):>99.0%

Bayyanar: Fari zuwa Kashe-Farin Crystalline Foda

Mai ƙarfi da zaɓin vasopressin V2 antagonist mai karɓa

API High Quality, Kasuwancin Kasuwanci

Inquiry: alvin@ruifuchem.com  


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Suna Tolvaptan
Sunan Sinadari N-[4- (9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide
Lambar CAS 150683-30-0
Lambar CAT RF-API101
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta Saukewa: C26H25ClN2O3
Nauyin Kwayoyin Halitta 448.94
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Kashe-White Crystalline Foda
Hanyoyin Ganewa IR, HPLC
Solubility Mai narkewa a cikin barasa na Benzyl da methanol amma Ba a iya narkewa a cikin Ruwa da Hexane
Tsarkake / Hanyar Bincike > 99.0% (HPLC)
Matsayin narkewa 219.0 ~ 222.0 ℃
Asara akan bushewa <0.50%
Ragowa akan Ignition <0.10%
Tsaftace Guda Daya <0.50%
Jimlar ƙazanta <1.00%
Karfe masu nauyi ≤20ppm
Ragowar Magani Haɗu da ƙayyadaddun bayanai
Matsayin Gwaji Matsayin Kasuwanci
Amfani API;Matsakaicin Magunguna

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

Aikace-aikace:

Tolvaptan (CAS: 150683-30-0), kuma aka sani da OPC-41061, wani zaɓi ne, mai gasa arginine vasopressin antagonist 2 antagonist da aka yi amfani da shi don magance hyponatremia (ƙananan matakan sodium na jini) wanda ke da alaƙa da gazawar zuciya, cirrhosis, da ciwo na rashin dacewa hormone antidiuretic (SIADH).Otsuka Pharmaceutical lasisi tolvaptan karkashin sunan kasuwanci Samsca bayan FDA ta amince da miyagun ƙwayoyi a watan Mayu 2009. Tolvaptan kuma ya nuna tasiri a kan polycystic koda cuta.A cikin gwaji na 2004, tolvaptan da aka gudanar tare da diuretics na gargajiya an lura da shi don ƙara yawan fitar da ruwa mai yawa da kuma inganta matakan sodium na jini a cikin marasa lafiya da ke fama da ciwon zuciya ba tare da haifar da sakamako masu illa irin su hypotension (ƙananan jini) ko hypokalemia (rage matakan jini na potassium).Har ila yau, miyagun ƙwayoyi bai nuna wani tasiri ba akan aikin koda.

Ku rubuta sakonku anan ku aiko mana